|
Brief Reports
Citations 211-220 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy
- Ping Zhou, Raymond L. Comenzo, Adam B. Olshen, Ezio Bonvini, Scott Koenig, Peter G. Maslak, Martin Fleisher, James Hoffman, Suresh Jhanwar, James W. Young, Stephen D. Nimer, and Adam M. Boruchov
Blood 2008; 111: 3403-3406.
[Abstract]
[Full text]
[PDF]
All primitive and definitive hematopoietic progenitor cells emerging before E10 in the mouse embryo are products of the yolk sac
- Christopher T. Lux, Momoko Yoshimoto, Kathleen McGrath, Simon J. Conway, James Palis, and Mervin C. Yoder
Blood 2008; 111: 3435-3438.
[Abstract]
[Full text]
[PDF]
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab
- Halvard Bonig, Annette Wundes, Kai-Hsin Chang, Sylvia Lucas, and Thalia Papayannopoulou
Blood 2008; 111: 3439-3441.
[Abstract]
[Full text]
[PDF]
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse
- Paolo Sportoletti, Silvia Grisendi, Samia M. Majid, Ke Cheng, John G. Clohessy, Agnes Viale, Julie Teruya-Feldstein, and Pier Paolo Pandolfi
Blood 2008; 111: 3859-3862.
[Abstract]
[Full text]
[PDF]
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
- Sai Li, Robert Kralovics, Gennaro De Libero, Alexandre Theocharides, Heinz Gisslinger, and Radek C. Skoda
Blood 2008; 111: 3863-3866.
[Abstract]
[Full text]
[PDF]
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor
- Wei-Li Zhao, Yan-Yan Liu, Qun-Ling Zhang, Li Wang, Christophe Leboeuf, Yi-Wen Zhang, Jie Ma, José-Francisco Garcia, Yong-Ping Song, Jun-Min Li, Zhi-Xiang Shen, Zhu Chen, Anne Janin, and Sai-Juan Chen
Blood 2008; 111: 3867-3871.
[Abstract]
[Full text]
[PDF]
The TNF (–308A) polymorphism is associated with microchimerism in transfused trauma patients
- Ryan M. Gill, Tzong-Hae Lee, Garth H. Utter, William F. Reed, Li Wen, Dan Chafets, and Michael P. Busch
Blood 2008; 111: 3880-3883.
[Abstract]
[Full text]
[PDF]
The monoclonal anti–VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
- Fabian Zohren, Diamandis Toutzaris, Viola Klärner, Hans-Peter Hartung, Bernd Kieseier, and Rainer Haas
Blood 2008; 111: 3893-3895.
[Abstract]
[Full text]
[PDF]
Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells
- Kazuhito Gotoh, Yoshihiko Tanaka, Akihiko Nishikimi, Ayumi Inayoshi, Munechika Enjoji, Ryoichi Takayanagi, Takehiko Sasazuki, and Yoshinori Fukui
Blood 2008; 111: 2973-2976.
[Abstract]
[Full text]
[PDF]
Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1
- Beatriz León and Carlos Ardavín
Blood 2008; 111: 3126-3130.
[Abstract]
[Full text]
[PDF]
|
|
